Log In
Print
BCIQ
Print
Print this Print this
 

ARGX-110

  Manage Alerts
Collapse Summary General Information
Company arGEN-X B.V.
DescriptionHuman mAb against CD70 (CD27L)
Molecular Target CD70 (CD27L)
Mechanism of Action 
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today